Haleon PLC Fireside Chat with Societe Generale SA Transcript
Good morning, everyone. Great to have you all on the line. I'm really pleased to introduce to Tobias Hestler, CFO of Haleon, who's with us today to run through our questions, as well as those submitted in advance by some of you on the line. So we've got about 50 minutes, so I suggest we just dive right in.
Thank you for joining us. If we can start with the outlook for top line at group level before delving down into some of the categories, your midterm sales growth target of 4% to 6% implies outperformance versus your expectations for growth of the consumer health care market of around 3% to 4%. And the midpoint of that range suggests market share is expected to grow by around 50 basis points or so over the next few years.
Can you sort of help us understand whether this outperformance is expected to come more from share gains in existing market? Or is new market entry a bigger element of that?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
